---
title: "Clene (CLNN) Gets a Buy from JonesTrading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286571471.md"
description: "JonesTrading analyst Justin Walsh has reiterated a Buy rating on Clene (CLNN) with a price target of $30.00. Canaccord Genuity also maintains a Buy rating with a $50.00 target. Walsh, a 5-star analyst, has an average return of 19.9% and a 38.79% success rate, focusing on the Healthcare sector."
datetime: "2026-05-15T12:40:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286571471.md)
  - [en](https://longbridge.com/en/news/286571471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286571471.md)
generator: "portal-rs"
---

# Clene (CLNN) Gets a Buy from JonesTrading

JonesTrading analyst Justin Walsh reiterated a Buy rating on Clene today and set a price target of $30.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Walsh is a 5-star analyst with an average return of 19.9% and a 38.79% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Praxis Precision Medicines, and Atai Beckley N.V..

In a report released today, Canaccord Genuity also reiterated a Buy rating on the stock with a $50.00 price target.

### Related Stocks

- [CLNN.US](https://longbridge.com/en/quote/CLNN.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [CATX.US](https://longbridge.com/en/quote/CATX.US.md)
- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)
- [ATAI.US](https://longbridge.com/en/quote/ATAI.US.md)
- [CLNNW.US](https://longbridge.com/en/quote/CLNNW.US.md)

## Related News & Research

- [Clene to present at Cantor Global Healthcare Conference, host investor meetings](https://longbridge.com/en/news/297910510.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)
- [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md)
- [Clene Targets Early Q4 NDA Filing for CNM-Au8 in ALS](https://longbridge.com/en/news/295645645.md)
- [Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained](https://longbridge.com/en/news/295433920.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**